Sandoz: UK Public Sector Contracts Won & Awards
Companies House: Private Limited Company·Camberley, Surrey·Nationwide (UK)·Main market: Pharmaceutical products
Official UK PPONPNQL-1548-CYBZ
i
How many tenders this supplier has won.
Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.
i
How many different public bodies have awarded to this supplier.
Buyers named on its awards, with duplicate names merged.
i
How much this supplier has won, by published values.
Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.
Not turnover. Not every award publishes a value.
i
Awards to this supplier in the last 12 months.
Award records dated in the last 12 months, against the two years before.
i
Contracts that finish in the next 18 months.
Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.
An end date does not confirm a new procurement.
i
In which regions this supplier wins work.
The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.
Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.
Where they wini
In which categories this supplier wins.
Distinct awards by the main category of the lot, or of the procedure when no lot is named. Repeat publications count once.
An award counts once in each class it covers; classes can overlap.
i
In which categories this supplier wins.
Distinct awards by the main category of the lot, or of the procedure when no lot is named. Repeat publications count once.
An award counts once in each class it covers; classes can overlap.
155 awards (150 for a named lot, 97%, 5 for a whole procedure with no lot named) · top CPV classes, shares of all 155 awards. An award may cover more than one class.
3360 Pharmaceutical products154 awards · 99% · 149 awards naming a lot + 5 whole-procedure awards3369 Various medicinal products1 awards · 1% · awards naming a loti
How much this supplier has won, by published values.
Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.
Not turnover. Not every award publishes a value.
i
What one of this supplier’s wins is usually worth.
Middle value of the same awards as the total above.
Largest published awards iThe biggest published awards. Awards to a single supplier with a published value, largest first, so you can check the totals against the notice. A repeated framework total can appear here. Open the notice to check. | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Transitional Drugs 3 | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | — | — | £7,180,657 † |
| Proprietary Drugs | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | — | — | £3,254,074 † |
| Proprietary Drugs | eTenderwales | — | — | £2,995,200 † |
| Generic Drugs - Tablets & Capsules | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | — | — | £2,801,383 † |
| Generic Drugs - Tablets & Capsules | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | — | — | £1,514,318 † |
Where their buyers arei
In which regions this supplier wins work.
The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.
Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.
i
In which regions this supplier wins work.
The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.
Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.
ITL1 region of the buyer office · known for 93 of 93 awarded procedures · each procedure counts once
Bidding recordi
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
Procurement Act 2023 award notices name every bidder · 7 notices name this supplier, covering 12 lots since 6 Oct 2025 · observed bids, not an estimate
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Frameworks and DPS this supplier got onto.
Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.
i
How many public bodies this supplier has bid to.
Buyers on notices that name it as a bidder, win or lose.
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointedall 3 lots bid for | 125 | 9 Oct 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 | NHS England | appointedall 2 lots bid for | 25 | 21 Jul 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | NHS England | appointedall 2 lots bid for | 26 | 10 Jul 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | NHS England | not appointed | 14 | 24 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | appointedall 2 lots bid for | 118 | 26 Feb 2026 |
| NHS National Framework for Denosumab Injection commencing 1st January 2026 | NHS England | not appointed | 13 | 4 Dec 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England | undecided | 17 | 6 Oct 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
Which public bodies award work to this supplier.
Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.
i
Which public bodies award work to this supplier.
Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
What kinds of public bodies award work to this supplier.
Its award records by the authority’s published type, otherwise by its name. One framework can add many records.
NHS & health83%(128 awards)
128 of 155 awards are NHS & health (83%).Central government11%(17 awards)
17 of 155 awards are Central government (11%).Type not classified6%(10 awards)
10 of 155 awards are Type not classified (6%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 32 | 34.4% | 58 | 27 Aug 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 15 | 16.1% | 25 | 9 Apr 2026 |
| Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | 13 | 14% | 13 | 13 Jun 2025 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 9 | 9.7% | 16 | 22 Aug 2024 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 8 | 8.6% | 19 | 12 Dec 2025 |
| The NHS Commissioning Board (operating under the name of NHS England) | 6 | 6.5% | 9 | 7 Feb 2022 |
| Regional Business Services Organisation Procurement and Logistics Service | 2 | 2.2% | 6 | 5 Jan 2026 |
| eTenderwales | 2 | 2.2% | 2 | 17 Jun 2025 |
Share = of the 93 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
Contracts that finish in the next 18 months.
Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.
An end date does not confirm a new procurement.
i
Contracts that finish in the next 18 months.
Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.
An end date does not confirm a new procurement.
126 of 155 awards carry an end date, 56 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Dasatinib Tablets | 3 Jan 2027 estimated | £79,792 |
| Range Generic & Biosimilar Cancer Medicines (unranked) | 3 Jan 2027 estimated | £1,714,852 |
| Etanercept | 19 Jan 2027 estimated | £1,700,000 |
| Infliximab IV | 19 Jan 2027 estimated | £44,300,000 |
| Generic Drugs - Tablets & Capsules | 31 Jan 2027 | £2,801,383 |
| Generic Anti-Infective Drugs | 31 Jan 2027 | £213,548 |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | 31 Jan 2027 | £1 |
| Wave 15b - Orals (plus non-parenteral) products | 31 Jan 2027 | £1 |
| Cancer Medicines (Group 2) | 31 Jan 2027 | £18,207,081 |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 |
Soonest 10 of 31.
Recent awards
Latest 30 of 155 award records naming this supplier
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions on this page are where the work is delivered, not the supplier’s registered address.
- Contract end dates. Published on 70 of 155 awards, estimated from the published duration on 56 more (marked “estimated”); those feed “Contracts ending”.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.